BerandaSHPHF • OTCMKTS
add
Sihuan Pharmaceutical Holdings Group Ltd
Tutup sebelumnya
$0,10
Rentang tahun
$0,049 - $0,12
Kapitalisasi pasar
9,93Â M HKD
Rasio P/E
-
Hasil dividen
-
Bursa utama
HKG
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CNY) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 475,71Â jt | 18,21% |
Biaya operasional | 501,94Â jt | 34,04% |
Laba bersih | -91,62Â jt | -4.090,21% |
Margin laba bersih | -19,26 | -3.466,67% |
Penghasilan per saham | — | — |
EBITDA | -139,89Â jt | -117,37% |
Tarif pajak efektif | 1,34% | — |
Neraca
Total aset
Total liabilitas
| (CNY) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 3,63Â M | -16,82% |
Total aset | 10,53Â M | -8,70% |
Total liabilitas | 5,58Â M | -12,76% |
Total ekuitas | 4,95 M | — |
Saham yang beredar | 9,24 M | — |
Harga terhadap nilai buku | 0,21 | — |
Tingkat pengembalian aset | -4,40% | — |
Tingkat pengembalian modal | -7,82% | — |
Arus Kas
Perubahan kas bersih
| (CNY) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -91,62Â jt | -4.090,21% |
Kas dari operasi | 103,71Â jt | 21,18% |
Kas dari investasi | 252,49Â jt | 626,42% |
Kas dari pembiayaan | -600,04Â jt | -512,13% |
Perubahan kas bersih | -243,84Â jt | -1.192,63% |
Arus kas bebas | 60,89Â jt | 155,48% |
Tentang
Sihuan Pharmaceutical is a Chinese pharmaceutical manufacturer with headquarters in Beijing and branch office in Haikou, Hainan Province. The main company in the group is the holding company Sihuan Pharmaceutical Holdings Group Ltd, which is listed on the Hong Kong stock market.
Sihuan Pharmaceutical is collaborating with the Academy of Military Medical Science in the development of the drug JK-05, intended for the treatment of Ebola virus disease. The company has been challenged by Fujifilm Holdings Corporation, which has stated that JK-05 infringes its patent rights regarding Avigan. Wikipedia
CEO
Didirikan
2001
Situs
Karyawan
2.667
